跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 50,427 条关于
“Lysosomal Storage Disorders”
全部
50,427
临床试验
44,732
药物
394
机构
114
资讯
5,187
10个月前
Polaryx Therapeutics Secures Nasdaq Listing Ahead of Phase 2 Trial for Rare Lysosomal Storage Disorders
7个月前
Azafaros to Present Phase 3 Nizubaglustat Data for Rare Lysosomal Storage Disorders at WORLDSymposium 2026
去年
Azafaros Secures €130M Funding to Advance Nizubaglustat into Phase III for Rare Lysosomal Storage Disorders
去年
Digital Health Technologies and AI Show Promise for Transforming Lysosomal Storage Disorder Care in Europe
去年
Azafaros to Present at J.P. Morgan's 43rd Annual Healthcare Conference
去年
Azafaros Secures €132M Series B Financing to Advance Rare Lysosomal Storage Disorder Treatments
去年
Chiesi Group and Key2Brain Expand Partnership with Worldwide Licensing Deal for Blood-Brain Barrier-Crossing Therapies
去年
Azafaros' Nizubaglustat Gains Orphan Drug Designations, Phase 3 Trials to Start in 2025
7个月前
JCR Pharmaceuticals Presents Promising Blood-Brain Barrier Data for Rare Disease Therapies at WORLDSymposium 2026
3个月前
Azafaros Publishes Phase 2 RAINBOW Study Data for Nizubaglustat in GM2 Gangliosidosis and Niemann-Pick Type C Disease
第 1 页，共 519 页
上一页
下一页
